ADL Amdl,

TUSTIN, Calif. and NEW YORK, June 21 /PRNewswire-FirstCall/ -- AMDL, INC. (AMEX:ADL), developer and marketer of cancer detection and vaccine technologies and with China-based pharmaceutical manufacturing, consumer sales and clinical trial activities, announced today that it will appear at the ValueRich Small-cap Financial Expo on June 21st at the W New York Hotel at 541 Lexington Ave. in New York City, between 49th and 50th Street. The conference, featuring top small cap companies nationwide, can be viewed at http://www.ivaluerich.com/expo.php . "This conference annually brings together top fund managers, money managers, institutional investors, research analysts and investment bankers and is an excellent forum to present the AMDL story," said Gary Dreher, CEO. "We are looking forward to update investors and potential investors on our achievements in China and our business strategies going forward." About AMDL: More information about AMDL and its products can be obtained at http://www.amdl.com/. Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur. Contact: Paul Knopick AMDL Investor Relations Direct Line: 949.707.5365 Voice Mail: 714.505.4460 DATASOURCE: AMDL, INC. CONTACT: Paul Knopick, Investor Relations for AMDL, INC., +1-949-707-5365, Voice Mail +1-714-505-4460 Web site: http://www.amdl.com/

Copyright